Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-11 Option Award | 2025-07-16 12:55 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Cashmere Karen A. Chief Commercial Officer | 48,100 | $0 | 48,100 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Freitag Gregory Gene Director | 11,066 | $0 | 11,066 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer | 136,900 | $0 | 136,900 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Finizio Robert G Director | 11,066 | $0 | 11,066 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer | 60,100 | $0 | 60,100 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Guzman Pablo A. Chief Medical Officer | 48,900 | $0 | 48,900 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | Park Min-Chul Director | 11,066 | $0 | 11,066 (Direct) | View |
| 2025-07-11 Option Award | 2025-07-15 4:22 pm | N/A 2035-07-11 | ZyVersa Therapeutics Inc. | ZVSA | SAPIRSTEIN JAMES Director | 11,066 | $0 | 11,066 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Cashmere Karen A. Director | 572 | $0 | 572 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer | 715 | $0 | 715 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer | 1,627 | $0 | 1,627 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Park Min-Chul Director | 132 | $0 | 132 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Freitag Gregory Gene Director | 132 | $0 | 132 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | SAPIRSTEIN JAMES Director | 132 | $0 | 132 (Direct) | View |
| 2023-05-24 Option Award | 2024-07-18 9:35 pm | N/A 2033-05-24 | ZyVersa Therapeutics Inc. | ZVSA | Finizio Robert G Director | 132 | $0 | 132 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-26 8:25 pm | N/A 2033-01-26 | ZyVersa Therapeutics Inc. | ZVSA | Guzman Pablo A. Chief Medical Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2023-01-26 8:22 pm | N/A N/A | ZyVersa Therapeutics Inc. | ZVSA | Guzman Pablo A. Chief Medical Officer | 0 | $0 | 107,934 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 4:00 pm | N/A N/A | ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer | 3,000 | $2.8815 | 44,585 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-16 9:41 pm | N/A 2027-12-12 | ZyVersa Therapeutics Inc. | ZVSA | INCON Co. Ltd. 10% Owner | 1,947,901 | $0 | 1,947,901 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:40 pm | N/A 2029-04-02 | ZyVersa Therapeutics Inc. | ZVSA | Finizio Robert G Director | 59,562 | $0 | 59,562 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:37 pm | N/A 2025-10-21 | ZyVersa Therapeutics Inc. | ZVSA | Wolfe Peter Chief Financial Officer | 174,648 | $0 | 174,648 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:34 pm | N/A 2031-07-01 | ZyVersa Therapeutics Inc. | ZVSA | Park Min-Chul Director | 39,708 | $0 | 39,708 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:31 pm | N/A 2024-04-11 | ZyVersa Therapeutics Inc. | ZVSA | LaBella Nicholas A. Jr. Chief Scientific Officer | 236,490 | $0 | 254,584 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:27 pm | N/A 2024-09-10 | ZyVersa Therapeutics Inc. | ZVSA | Cashmere Karen A. Chief Commercial Officer | 103,242 | $0 | 103,242 (Direct) | View |
| 2022-12-12 Option Award | 2022-12-14 7:24 pm | 2022-12-12 N/A | ZyVersa Therapeutics Inc. | ZVSA | Glover Stephen C. Chief Executive Officer | 1,499,542 | $0 | 1,366,196 (Direct) | View |
| 2022-12-12 Other | 2022-12-14 7:21 pm | 2022-12-12 N/A | ZyVersa Therapeutics Inc. | ZVSA | O'Connor Daniel J. Larkspur Health LLC Director 10% Owner | 1,558,302 | $0 | 2,935,900 (Direct) | View |
| 2022-01-06 Other | 2022-03-10 5:32 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | Larkspur Health LLC 10% Owner | 239,700 | $0 | 1,613,872 (Direct) | View |
| 2022-01-06 Other | 2022-03-10 5:32 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | Mehra Raj Director | 953 | $0 | 8,631 (Direct) | View |
| 2022-01-06 Other | 2022-03-10 5:31 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | O'Connor Daniel J. Chief Executive Officer | 66,018 | $0 | 487,097 (Indirect) | View |
| 2022-01-06 Other | 2022-03-10 5:30 pm | N/A N/A | Larkspur Health Acquisition Corp. | LSPR | Twitty Christopher Director | 953 | $0 | 8,631 (Direct) | View |